International uniform response criteria for multiple myelomaBrian G.M. Durie, Jan Westin, Pieter Sonneveld et al.|Leukemia|2006Cited by 2.6k
Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group studyShaji Kumar, J H Lee, Juan José Lahuerta et al.|Leukemia|2011Cited by 721
The IASLC Lung Cancer Staging Project: Proposals for the Revision of the T Descriptors in the Forthcoming (Seventh) Edition of the TNM Classification for Lung CancerRamón Rami–Porta, Peter Goldstraw, David Ball et al.|Journal of Thoracic Oncology|2007Cited by 637
The IASLC Lung Cancer Staging Project: Proposals for the Revision of the N Descriptors in the Forthcoming Seventh Edition of the TNM Classification for Lung CancerValerie W. Rusch, Johan Vansteenkiste, Dorothy J. Giroux et al.|Journal of Thoracic Oncology|2007Cited by 523
A phase II evaluation of tamoxifen in unresectable or refractory meningiomas: a southwest oncology group studyJ. Wendall Goodwin, Jeannette J. Townsend, John Crowley et al.|Journal of Neuro-Oncology|1993Cited by 179